Advertisement


Kerri M. Winters-Stone, PhD, on Peripheral Neuropathy: High Prevalence Among Female Survivors

2016 Cancer Survivorship Symposium

Advertisement

Kerri M. Winters-Stone, PhD, of Oregon Health and Science University, discusses the results of her study, which showed that, years after treatment, nearly half of women cancer survivors still have symptoms of chemotherapy-induced peripheral neuropathy. The findings may inform rehabilitative programs to prevent falls and injuries (Abstract 130).



Related Videos

Survivorship
Thyroid Cancer

Dana Barnea, MD, on Screening Survivors for Thyroid Cancer

Dana Barnea, MD, of Memorial Sloan Kettering Cancer Center, discusses data that suggest annual palpation of the thyroid is an adequate and safe means of screening childhood and young adult cancer survivors, a population at high risk for this type of cancer (Abstract 254).

Survivorship
Breast Cancer

Craig E. Pollack, MD, on Low-Income Breast Cancer Survivors: Clinical Trial Results

Craig E. Pollack, MD, of Johns Hopkins University, discusses a study of survivorship care plans for this special population (Abstract 1).

Survivorship
Breast Cancer

Jennifer A. Ligibel, MD, on Breast Cancer Survivorship in Young Women

Jennifer A. Ligibel, MD, of the Dana-Farber Cancer Institute, discusses the physical activity behaviors and weight changes in a study cohort of young women with breast cancer (Abstract 166).

Survivorship

Christopher J. Recklitis, PhD, MPH, on Fatigue and Sleep Disturbances

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses these side effects and some practical approaches to managing them with educational, medical, behavioral, and lifestyle interventions.

Survivorship

Mary S. McCabe, RN, on Risk-Based Health Care of Cancer Survivors

Mary McCabe, RN, of Memorial Sloan Kettering Cancer Center, discusses various models of delivering survivorship care.

Advertisement

Advertisement




Advertisement